Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer

SIMPLE SUMMARY: The conventional methods that seek to predict clinical treatment response are based on the number of circulating tumor cells (CTCs) present in liquid biopsies or genetic profiling of extracted CTCs. This paper presents a novel process by which CTCs can be extracted from blood samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kuan-Chou, Ting, Lai-Lei, Chang, Chia-Lun, Lu, Long-Sheng, Lee, Hsin-Lun, Hsu, Fang-Chi, Chiou, Jeng-Fong, Wang, Peng-Yuan, Burnouf, Thierry, Ho, Dennis Chun-Yu, Yang, Kai-Chiang, Chen, Chang-Yu, Chen, Chu-Huang, Wu, Ching-Zong, Chen, Yin-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656523/
https://www.ncbi.nlm.nih.gov/pubmed/34885184
http://dx.doi.org/10.3390/cancers13236076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656523/
https://www.ncbi.nlm.nih.gov/pubmed/34885184
http://dx.doi.org/10.3390/cancers13236076

Ejemplares similares